Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells

Placenta

Volumn 32, Issue 1, 2011, Pages 70-78

  Rajakumar, A ^a,b   Chu, T ^a,b   Handley, D E ^b   Bunce, K D ^b   Burke, B ^b   Hubel, C A ^a,b   Jeyabalan, A ^a,b   Peters, D G ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Miccroarray; Peripheral blood mononuclear cells (PBMCs); Preeclampsia; Pregnancy

Indexed keywords

CAVEOLIN; FIBRONECTIN; GELATINASE B; INTERLEUKIN 4; MESSENGER RNA; PROTEIN; STAT1 PROTEIN; SURVIVIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTOME; UNCLASSIFIED DRUG; WAP FOUR DISULFIDE DOMAIN PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MICROARRAY ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; ZYMOGRAPHY;

ADULT; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES, MONONUCLEAR; MICROARRAY ANALYSIS; MOTHERS; PRE-ECLAMPSIA; PREGNANCY; VALIDATION STUDIES AS TOPIC;

EID: 78650514427     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2010.10.004     Document Type: Article

References (45)

1. L. Duley The global impact of preeclampsia and eclampsia Semin Perinatol 33 3 2009 Jun 130 137
2. F.C. Luft Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a preeclampsia molecule Nephrol Dial Transplant 21 11 2006 Nov 3052 3054
3. P. ten Dijke, M.J. Goumans, and E. Pardali Endoglin in angiogenesis and vascular diseases Angiogenesis 11 1 2008 79 89
4. N. Kita, and J. Mitsushita A possible placental factor for preeclampsia: sFlt-1 Curr Med Chem 15 7 2008 711 715
5. S. Maynard, F.H. Epstein, and S.A. Karumanchi Preeclampsia and angiogenic imbalance Annu Rev Med 59 2008 61 78
6. S.A. Founds, Y.P. Conley, J.F. Lyons-Weiler, A. Jeyabalan, W.A. Hogge, and K.P. Conrad Altered global gene expression in first trimester placentas of women destined to develop preeclampsia Placenta 30 1 2009 Jan 15 24
7. C.W. Redman, and I.L. Sargent Preeclampsia, the placenta and the maternal systemic inflammatory response-a review Placenta 24 Suppl. A 2003 Apr S21 S27
8. C.A. Hubel Oxidative stress in the pathogenesis of preeclampsia Proc Soc Exp Biol Med 222 3 1999 Dec 222 235
9. C.W. Redman, and I.L. Sargent Preeclampsia and the systemic inflammatory response Semin Nephrol 24 6 2004 Nov 565 570
10. S. Okazaki, A. Sekizawa, Y. Purwosunu, A. Farina, N. Wibowo, and T. Okai Placenta-derived, cellular messenger RNA expression in the maternal blood of preeclamptic women Obstet Gynecol 110 5 2007 Nov 1130 1136
11. C.J. Sun, L. Zhang, and W.Y. Zhang Gene expression profiling of maternal blood in early onset severe preeclampsia: identification of novel biomarkers J Perinat Med 37 6 2009 609 616
12. J.M. Roberts, G. Pearson, J. Cutler, and M. Lindheimer Summary of the NHLBI working group on research on hypertension during pregnancy Hypertension 41 3 2003 Mar 437 445 (Pubitemid 36314613)
13. T. Lind, K.A. Godfrey, H. Otun, and P.R. Philips Changes in serum uric acid concentrations during normal pregnancy Br J Obstet Gynaecol 91 2 1984 Feb 128 132
14. Y.H. Yang, S. Dudoit, P. Luu, D.M. Lin, V. Peng, and J. Ngai Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation Nucleic Acids Res 30 4 2002 Feb 15 e15
15. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J Royal Stat Soc Ser B (Methodological) 57 1995 289 300
16. A. Reiner, D. Yekutieli, and Y. Benjamini Identifying differentially expressed genes using false discovery rate controlling procedures Bioinformatics 19 3 2003 Feb 12 368 375
17. Systems I. Ingenuity Pathways Analysis. Ingenuity Pathways Analysis 2008.
18. A. Rajakumar, K. Doty, A. Daftary, N. Markovic, and K.P. Conrad Expression of von Hippel Lindau (pVHL) protein in placentae from normal pregnant women and women with preeclampsia Placenta 27 4-5 2006 Apr-May 411 421
19. L.K. Wagner Diagnosis and management of preeclampsia Am Fam Physician 70 12 2004 Dec 15 2317 2324
20. L. Vogt, N. Schmitz, M.O. Kurrer, M. Bauer, H.I. Hinton, and S. Behnke VSIG4, a B7 family-related protein, is a negative regulator of T cell activation J Clin Invest 116 10 2006 Oct 2817 2826
21. Y. Ikehara, S.K. Ikehara, and J.C. Paulson Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9 J Biol Chem 279 41 2004 Oct 8 43117 43125
22. K.A. Hotchkiss, A.W. Ashton, and E.L. Schwartz Thymidine phosphorylase and 2-deoxyribose stimulate human endothelial cell migration by specific activation of the integrins alpha 5 beta 1 and alpha V beta 3 J Biol Chem 278 21 2003 May 23 19272 19279
23. N. Kikuno, T. Yoshino, S. Urakami, K. Shigeno, H. Kishi, and K. Hata The role of thymidine phosphorylase (TP) mRNA expression in angiogenesis of prostate cancer Anticancer Res 23 2B 2003 Mar-Apr 1305 1312
24. L. Cheng, H. Jia, M. Lohr, A. Bagherzadeh, D.I. Holmes, and D. Selwood Anti-chemorepulsive effects of vascular endothelial growth factor and placental growth factor-2 in dorsal root ganglion neurons are mediated via neuropilin-1 and cyclooxygenase-derived prostanoid production J Biol Chem 279 29 2004 Jul 16 30654 30661
25. S.A. Karumanchi, and M.D. Lindheimer Advances in the understanding of eclampsia Curr Hypertens Rep 10 4 2008 Aug 305 312
26. M. Blumenstein, M.T. McMaster, M.A. Black, S. Wu, R. Prakash, and J. Cooney A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease Proteomics 9 11 2009 Jun 2929 2945
27. T. Varkonyi, B. Nagy, T. Fule, A.L. Tarca, K. Karaszi, and J. Schonleber Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and Preeclampsia are similar Placenta 11 2010 Jun
28. V. Sitras, R.H. Paulssen, H. Gronaas, J. Leirvik, T.A. Hanssen, and A. Vartun Differential placental gene expression in severe preeclampsia Placenta 30 5 2009 May 424 433
29. S. Polager, and D. Ginsberg E2F - at the crossroads of life and death Trends Cell Biol 18 11 2008 Nov 528 535
30. J.M. Blanchard Cyclin A2 transcriptional regulation: modulation of cell cycle control at the G1/S transition by peripheral cues Biochem Pharmacol 60 8 2000 Oct 15 1179 1184
31. M. Joaquin, and R.J. Watson Cell cycle regulation by the B-Myb transcription factor Cell Mol Life Sci 60 11 2003 Nov 2389 2401
32. S. Madar, R. Brosh, Y. Buganim, O. Ezra, I. Goldstein, and H. Solomon Modulated expression of WFDC1 during carcinogenesis and cellular senescence Carcinogenesis 30 1 2009 Jan 20 27
33. N.P. Weng, K. Liu, M. Catalfamo, Y. Li, and P.A. Henkart IL-15 is a growth factor and an activator of CD8 memory T cells Ann N Y Acad Sci 975 2002 Dec 46 56
34. W.E. Carson, J.G. Giri, M.J. Lindemann, M.L. Linett, M. Ahdieh, and R. Paxton Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor J Exp Med 180 4 1994 Oct 1 1395 1403
35. I.L. Sargent, A.M. Borzychowski, and C.W. Redman NK cells and preeclampsia J Reprod Immunol 76 1-2 2007 Dec 40 44
36. A. Hennessy, S. Orange, N. Willis, D.M. Painter, A. Child, and J.S. Horvath Transforming growth factor-beta 1 does not relate to hypertension in preeclampsia Clin Exp Pharmacol Physiol 29 11 2002 Nov 968 971
37. H.O. Pae, Y.C. Lee, and H.T. Chung Heme oxygenase-1 and carbon monoxide: emerging therapeutic targets in inflammation and allergy Recent Pat Inflamm Allergy Drug Discov 2 3 2008 159 165
38. Z.A. Iskandar, and F.S. Al-Joudi Expression of survivin in fetal and adult normal tissues of rat Malays J Pathol 28 2 2006 Dec 101 105
39. Y. Jiang, H.I. Saavedra, M.P. Holloway, G. Leone, and R.A. Altura Aberrant regulation of survivin by the RB/E2F family of proteins J Biol Chem 279 39 2004 Sep 24 40511 40520
40. A. Yoshimura, Y. Kuwazuru, T. Furukawa, H. Yoshida, K. Yamada, and S. Akiyama Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors Biochim Biophys Acta 1034 1 1990 Apr 23 107 113
41. J. Jarvenpaa, J.T. Vuoristo, E.R. Savolainen, O. Ukkola, T. Vaskivuo, and M. Ryynanen Altered expression of angiogenesis-related placental genes in preeclampsia associated with intrauterine growth restriction Gynecol Endocrinol 23 6 2007 Jun 351 355
42. S. Sakao, L. Taraseviciene-Stewart, C.D. Cool, Y. Tada, Y. Kasahara, and K. Kurosu VEGF-R blockade causes endothelial cell apoptosis, expansion of surviving CD34+ precursor cells and transdifferentiation to smooth muscle-like and neuronal-like cells FASEB J 21 13 2007 Nov 3640 3652
43. J.A. Russell Substance P elicits thromboxane-induced contraction of canine pulmonary veins Pulm Pharmacol 1 3 1988 153 159
44. P. Needleman, M. Minkes, and A. Raz Thromboxanes: selective biosynthesis and distinct biological properties Science 193 4248 1976 Jul 9 163 165
45. R.A. Benndorf, E. Schwedhelm, A. Gnann, R. Taheri, G. Kom, and M. Didie Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis Circ Res 103 9 2008 Oct 24 1037 1046